ARG1
Arginase-1
Also known as: ARGI1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05089
- Gene
- ARG1
- Ensembl
- ENSG00000118520
- Chromosome
- 6
- Canonical length
- 322 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
322 residues, UniProt reviewed canonical sequence.
>P05089|ARG1
1 MSAKSRTIGI IGAPFSKGQP RGGVEEGPTV LRKAGLLEKL KEQECDVKDY GDLPFADIPN
61 DSPFQIVKNP RSVGKASEQL AGKVAEVKKN GRISLVLGGD HSLAIGSISG HARVHPDLGV
121 IWVDAHTDIN TPLTTTSGNL HGQPVSFLLK ELKGKIPDVP GFSWVTPCIS AKDIVYIGLR
181 DVDPGEHYIL KTLGIKYFSM TEVDRLGIGK VMEETLSYLL GRKKRPIHLS FDVDGLDPSF
241 TPATGTPVVG GLTYREGLYI TEEIYKTGLL SGLDIMEVNP SLGKTPEEVT RTVNTAVAIT
301 LACFGLAREG NHKPIDYLNP PKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 1,125 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,125 nTPM
- bone marrow: 276 nTPM
- skin: 97 nTPM
- spleen: 22 nTPM
- lung: 6.7 nTPM
- breast: 4.5 nTPM
Single-cell type
- neutrophil progenitors: 1,427 nCPM
- hepatocytes: 1,283 nCPM
- neutrophils: 944 nCPM
- esophageal apical cells: 32 nCPM
- hepatic stellate cells: 19 nCPM
- cholangiocytes: 15 nCPM
Immune cell
- neutrophil: 45 nTPM
- T-reg: 9.4 nTPM
- memory CD4 T-cell: 1 nTPM
- non-classical monocyte: 0.9 nTPM
- naive CD4 T-cell: 0.7 nTPM
- total PBMC: 0.4 nTPM
Brain region
- cerebellum: 2.5 nTPM
- cerebral cortex: 1.4 nTPM
- medulla oblongata: 1.4 nTPM
- pons: 1.1 nTPM
- hippocampal formation: 1 nTPM
- choroid plexus: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARG1.
Disease | AllUniProt
Conditions ARG1 is implicated in, by any mechanism.
- Argininemia (ARGIN) MIM:207800
Disease | GeneticClinVar
139 pathogenic / likely-pathogenic of 579 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arginase deficiency
- ARG1-related disorder
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on ARG1 was assayed in.
- breast cancer T cell
- skin melanoma T cell
- melanoma T cell
- rectum cancer T cell
- ovarian cancer T cell
- ocular melanoma T cell
- colon cancer T cell
- myeloproliferative neoplasm T cell
- multiple myeloma T cell
- polycythemia vera T cell
- essential thrombocythemia T cell
- myelofibrosis T cell
- renal cell carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- defense response to protozoan
- innate immune response
- L-arginine catabolic process
- negative regulation of activated T cell proliferation
- negative regulation of T cell proliferation
- negative regulation of T-helper 2 cell cytokine production
- negative regulation of type II interferon-mediated signaling pathway
- response to nematode
- urea cycle
- positive regulation of neutrophil mediated killing of fungus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARG1 as an antibody target. Whether an autoantibody or antibody against ARG1 could matter depends on whether native ARG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...